Vol 18, No 1 (2015)
Research paper
Published online: 2015-01-29

open access

Page views 1366
Article views/downloads 1827
Get Citation

Connect on Social Media

Connect on Social Media

The role of 18F fluorodeoxyglucose positron emission tomography (18F-FDG-PET) in children with rheumatic carditis and chronic rheumatic heart disease

Chamarajnagar Mahadevappa Nagesh, Anita Saxena, Chetan Patel, Sellam Karunanithi, Murli Nadig, Arun Malhotra
DOI: 10.5603/NMR.2015.0006
Pubmed: 25633513
Nucl. Med. Rev 2015;18(1):25-28.

Abstract

BACKGROUND: We report the use of positron emission tomography (PET) using 18F-FDG for the diagnosis of carditis in children with rheumatic heart disease (RHD).

MATERIAL AND METHODS: Thirty-six children aged 6–17 years (seventeen males and nineteen females) with isolated rheumatic significant mitral regurgitation (MR) underwent FDG-PET scanning of the heart after fasting for 6 h within a period of 2 years. They were divided into two groups based on Jones criteria — acute rheumatic carditis and chronic RHD. Age- and gender-matched twelve children who underwent whole body 18F-FDG-PET scan for routine PET scan for oncological evaluation was taken as controls. Nineteen patients had active carditis and 17 were chronic RHD cases.

RESULTS: All 12 controls and all 17 cases with chronic RHD with MR showed diffuse uptake pattern. Of the 19 active cases, 14 showed 18F-FDG uptake in the myocardium, 5 did not show any uptake. Thus the finding of no uptake pattern on 18F-FDG-PET scan had a sensitivity of 26% but positive predictive value of 100% for acute carditis cases. This study describes the 18F-FDG-PET uptake pattern in children with RHD and in 12 age-matched control subjects in the fasting state. Those with chronic RHD with MR showed diffuse myocardial uptake pattern similar to that of the control group. Patients with active carditis showed mixed results; the majority showed diffuse uptake pattern.

CONCLUSION: In view of its poor sensitivity, 18F-FDG-PET is not recommended as a routine imaging modality for the diagnosis of rheumatic carditis.